Browse drugs

…nib vs traditional drugs mechanism, IDDF2026-ABS-0129 Figure 2. Nintedanib efficacy in IBD fibrosis).Conclusions In the DSS-induced mouse …

… control remained at F4. (IDDF2026-ABS-0196 Table 1)Conclusions Luseogliflozin added to standard therapy improved liver fibrosis scores, glyce…

…apy). The carboxylated MSN surface was sequentially loaded with metformin (Me), chlorin e6 (Ce6), and glucose oxidase (GOX), constructing…

…5% CI 0.454-0.945, p=0.024), were independently associated with UDCA treatment failure (IDDF2026-ABS-0398 Figure 1).Conclusions Earl…

… formation. Intravenous, oral or intratumoral administration of C92 as a single agent led to robust antitumor immune responses and …

…c maltol for postoperative anaemia in CRC is feasible and safe. Ferric maltol provided evidence of iron repletion. Preliminary signals for im…

… rates and stable clinical disease activity and biomarkers with ustekinumab biosimilars. Biosimilar ustekinumab was well tolerated and appe…

…Introduction Elective discontinuation of Vedolizumab (VDZ) may be considered in patients achieving deep remission, b…

…ived from BSG guidance and received an OGD prior to initiation. Sucralfate has shown to have a positive effect on patient’s endoscopic fin…

…rse endoscopists (93.9% vs 92.5% vs 88.2%, p<0.001). The use of midazolam was higher in medical physicians, compared to surgeons and non-…

…Introduction Elafibranor (ELA), a peroxisome proliferator-activated receptor (PPAR)α/PPA…

…ty (53% of patients who had a discussion) gave consent to begin statins. Only 28 (56% of consenting patients) were prescribed a statin.…